Ligand profile
CEW
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_1655 — penicillin-binding protein 6
Identifiers
Database identifiers and provenance.
- Ligand ID
CEW- PDB
3hum- UniProt (similar protein)
A0A0H2WY27- Target protein
- VK055_1655
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 155.1
- −1 ≤ LogP ≤ 5 -0.89
- MW ≤ 500 Da 401.5
- LogP ≤ 5 -0.89
- H-bond donors ≤ 5 5
- H-bond acceptors ≤ 10 10
- Rotatable bonds ≤ 10 7
- TPSA ≤ 140 Ų 155.1
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CC1=C(N[C@H](SC1)[C@@H](C=O)NC(=O)C(=NOC)C2=CSC(N2)N)C(=O)OCC1=C(N[C@H](SC1)[C@@H](C=O)NC(=O)C(=NOC)C2=CSC(N2)N)C(=O)O
InChI=1S/C14H19N5O5S2/c1-6-4-25-12(18-9(6)13(22)23)7(3-20)16-11(21)10(19-24-2)8-5-26-14(15)17-8/h3,5,7,12,14,17-18H,4,15H2,1-2H3,(H,16,21)(H,22,23)/t7-,12-,14?/m1/s1InChI=1S/C14H19N5O5S2/c1-6-4-25-12(18-9(6)13(22)23)7(3-20)16-11(21)10(19-24-2)8-5-26-14(15)17-8/h3,5,7,12,14,17-18H,4,15H2,1-2H3,(H,16,21)(H,22,23)/t7-,12-,14?/m1/s1
FAPGDVXEBFTUCY-CVBWJICYSA-NFAPGDVXEBFTUCY-CVBWJICYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00144' 'PF00768
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand CEW →
- PDB RCSB structure 3hum →
- UniProt UniProt A0A0H2WY27 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CEW”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_1655.
PDB 13
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 1
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).